Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank86
3Y CAGR+23.4%
5Y CAGR+103.0%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+23.4%/yr
Annual compound
5Y CAGR
+103.0%/yr
Recent deceleration
Percentile
P86
Within normal range
vs 5Y Ago
34.5x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.17 | -13.3% |
| 2024 | 0.19 | +68.9% |
| 2023 | 0.11 | +28.3% |
| 2022 | 0.09 | +739.0% |
| 2021 | 0.01 | +118.7% |
| 2020 | 0.00 | +71.8% |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |